RegenETP, Inc.
Other OTCTotal Valuation
RegenETP, Inc. carries a market capitalization of 1.18M, placing it among publicly traded companies globally. Its enterprise value stands at -160,207.00, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.18M |
| Enterprise Value | -160,207.00 |
Share Statistics
RegenETP, Inc. currently has 7.33M shares outstanding.
| Shares Outstanding | 7.33M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 44.94, and the price-to-book ratio stands at -0.01.
| PE Ratio | N/A |
| PS Ratio | 44.94 |
| PB Ratio | -0.01 |
| P/TBV Ratio | 0.26 |
| P/FCF Ratio | -0.15 |
| P/OCF Ratio | -0.15 |
Enterprise Valuation
| EV / Sales | 3.01 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
RegenETP, Inc. maintains a current ratio of 4.11, meaning it holds 4.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.77, indicating elevated leverage, while an interest coverage ratio of 5,151.00 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 4.11 |
| Quick Ratio | 3.15 |
| Debt / Equity | 23.77 |
| Debt / EBITDA | -0.14 |
| Interest Coverage | 5,151.00 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -34.54 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
RegenETP, Inc.'s stock has gained approximately 433.33333% over the past 52 weeks. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | 433.33333% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.12 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, RegenETP, Inc. generated 73,000.00 in revenue and converted that into -8.30M in net income, yielding earnings per share of -1.25. EBITDA reached -20.60M, while operating income came in at -21.80M.
| Revenue | 73,000.00 |
| Gross Profit | -52,000.00 |
| Operating Income | -21.80M |
| Pretax Income | -8.30M |
| Net Income | -8.30M |
| EBITDA | -20.60M |
| EBIT | -21.80M |
| Earnings Per Share (EPS) | -1.25 |
Balance Sheet
RegenETP, Inc. holds 6.39M in cash and equivalents against 2.95M in total debt, resulting in a net debt position of -6.39M. Total book value stands at -520.47M, with working capital of 6.76M providing operational flexibility.
| Cash & Cash Equivalents | 6.39M |
| Total Debt | 2.95M |
| Net Debt | -6.39M |
| Equity (Book Value) | -520.47M |
| Book Value Per Share | -79.32 |
| Working Capital | 6.76M |
Cash Flow
RegenETP, Inc. produced -21.64M in operating cash flow over the past twelve months. After subtracting -6,000.00 in capital expenditures, free cash flow totaled -21.64M - equivalent to -3.30 per share.
| Operating Cash Flow | -21.64M |
| Capital Expenditures | -6,000.00 |
| Free Cash Flow | -21.64M |
| FCF Per Share | -3.30 |
Margins
RegenETP, Inc. operates with a gross margin of -71.23, reflecting its pricing power and cost economics. The operating margin of -29,868.49 and net profit margin of -11,376.71 provide insight into operational efficiency.
| Gross Margin | -71.23 |
| Operating Margin | -29,868.49 |
| Pretax Margin | -11,376.71 |
| Profit Margin | -11,376.71 |
| EBITDA Margin | -28,224.66 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -197.06 |
| FCF Yield | -650.36 |
Stock Splits
RegenETP, Inc.'s most recent stock split took place on May 17, 2022 with a 25:1 split ratio.
| Last Split Date | 5/17/2022 |
| Split Ratio | 25:1 |
Scores
RegenETP, Inc. posts an Altman Z-Score of -43.56, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -43.56 |